Mary Ann Liebert: Labeling of Cannabidiol Products Becoming a Public Health Concern
March 26, 2020
March 26, 2020
NEW ROCHELLE, New York, March 26 -- Mary Ann Liebert Inc. issued the following news release:
The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue. Despite CBD being a U.S. Food and Drug Administration-approved drug, it is increasingly being added to food, beverages, and nutritional supplements, often with misleading labeling or marketing claims, according to an article published in Cannabis and Cannabino . . .
The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue. Despite CBD being a U.S. Food and Drug Administration-approved drug, it is increasingly being added to food, beverages, and nutritional supplements, often with misleading labeling or marketing claims, according to an article published in Cannabis and Cannabino . . .